.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03A_DrugsForFunctionalGastrointestinalDisorders.A03AB18_PrifiniumBromide.PrifiniumBromide .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03A_DrugsForFunctionalGastrointestinalDisorders.A03AB18_PrifiniumBromide.PrifiniumBromide| name: | PrifiniumBromide | |
| ATC code: | A03AB18 | route: | oral |
| compartments: | 1 | |
| dosage: | 15 | mg |
| volume of distribution: | 1.2 | L |
| clearance: | 0.065 | L/kg/h |
| other parameters in model implementation | ||
Prifinium bromide is an anticholinergic agent that acts as a muscarinic receptor antagonist, previously used to relieve gastrointestinal spasms, irritable bowel syndrome, and related motility disorders. It is no longer widely approved or used in many countries today.
No peer-reviewed primary literature found reporting human pharmacokinetic parameters of prifinium bromide. The following values are estimated using class-consensus and physicochemical property-based prediction (see notes).